Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hecker

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Genes & Development|July 1, 1992
Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamstersR Hecker, A Taraboulos, M Scott, et al.
Anesthesiology|February 1, 1984
Bupivacaine cardiotoxicity in a pregnant patient with mitral valve prolapse: an example of improperly administered epidural blockM S Batra, L D Bridenbaugh, C B Caldwell, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1988
Olsalazine in the treatment of active ulcerative colitis: a placebo controlled clinical trial and assessment of drug dispositionD J Hetzel, D J Shearman, J Labrooy, et al.
Veterinary Immunology and Immunopathology|May 7, 2004
In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheepA K Nichani, A Mena, Y Popowych, et al.
Veterinary Immunology and Immunopathology|February 5, 2002
Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifsR A Pontarollo, R Rankin, L A Babiuk, et al.
The Medical Journal of Australia|January 4, 1988
Preliminary experience with a combined-modality approach to the management of oesophageal cancerJ W Denham, P G Gill, G G Jamieson, et al.
Antisense & Nucleic Acid Drug Development|September 5, 2003
Safety of CpG oligodeoxynucleotides in veterinary speciesX P Ioannou, P Griebel, A Mena, et al.
Vaccine|July 20, 2002
CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein DR Rankin, R Pontarollo, S Gomis, et al.
Journal of Medicinal Chemistry|August 2, 1996
Potent thrombin inhibitors that probe the S1 subsite: tripeptide transition state analogues based on a heterocycle-activated carbonyl groupM J Costanzo, B E Maryanoff, L R Hecker, et al.
Veterinary Immunology and Immunopathology|May 25, 2005
Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosisD N Wedlock, M A Skinner, G W de Lisle, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Genes & Development|July 1, 1992
Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamstersR Hecker, A Taraboulos, M Scott, et al.
Anesthesiology|February 1, 1984
Bupivacaine cardiotoxicity in a pregnant patient with mitral valve prolapse: an example of improperly administered epidural blockM S Batra, L D Bridenbaugh, C B Caldwell, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1988
Olsalazine in the treatment of active ulcerative colitis: a placebo controlled clinical trial and assessment of drug dispositionD J Hetzel, D J Shearman, J Labrooy, et al.
Veterinary Immunology and Immunopathology|May 7, 2004
In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheepA K Nichani, A Mena, Y Popowych, et al.
Veterinary Immunology and Immunopathology|February 5, 2002
Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifsR A Pontarollo, R Rankin, L A Babiuk, et al.
The Medical Journal of Australia|January 4, 1988
Preliminary experience with a combined-modality approach to the management of oesophageal cancerJ W Denham, P G Gill, G G Jamieson, et al.
Antisense & Nucleic Acid Drug Development|September 5, 2003
Safety of CpG oligodeoxynucleotides in veterinary speciesX P Ioannou, P Griebel, A Mena, et al.
Vaccine|July 20, 2002
CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein DR Rankin, R Pontarollo, S Gomis, et al.
Journal of Medicinal Chemistry|August 2, 1996
Potent thrombin inhibitors that probe the S1 subsite: tripeptide transition state analogues based on a heterocycle-activated carbonyl groupM J Costanzo, B E Maryanoff, L R Hecker, et al.
Veterinary Immunology and Immunopathology|May 25, 2005
Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosisD N Wedlock, M A Skinner, G W de Lisle, et al.
Pageof 11